230 related articles for article (PubMed ID: 35626252)
21. Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome.
Abid MSR; Qiu H; Tripp BA; de Lima Leite A; Roth HE; Adamec J; Powers R; Checco JW
Sci Rep; 2022 May; 12(1):8289. PubMed ID: 35585122
[TBL] [Abstract][Full Text] [Related]
22. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.
Lee YK; Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
Sci Rep; 2021 Aug; 11(1):17258. PubMed ID: 34446784
[TBL] [Abstract][Full Text] [Related]
23. Evaluating symptom severity and urinary cytokine levels in interstitial cystitis/bladder pain syndrome patients, with and without Hunner's lesions.
Zwaans BM; Mota S; Bartolone SN; Ward EP; Peters KM; Chancellor MB
Am J Clin Exp Urol; 2024; 12(2):110-118. PubMed ID: 38736620
[TBL] [Abstract][Full Text] [Related]
24. Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.
Corcoran AT; Yoshimura N; Tyagi V; Jacobs B; Leng W; Tyagi P
World J Urol; 2013 Feb; 31(1):241-6. PubMed ID: 22441309
[TBL] [Abstract][Full Text] [Related]
25. Bioenergetic profiles of peripheral mononuclear cells and systemic inflammation in women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Kumar P; Oster RA; Assimos DG; Ness TJ; Mitchell T
PLoS One; 2024; 19(2):e0298981. PubMed ID: 38359038
[TBL] [Abstract][Full Text] [Related]
26. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
27. Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan.
Yu WR; Kuo HC
Low Urin Tract Symptoms; 2024 Jan; 16(1):e12508. PubMed ID: 37987028
[TBL] [Abstract][Full Text] [Related]
28. Autonomic response during bladder hydrodistention reflects the severity of symptoms in patients with bladder pain syndrome/interstitial cystitis.
Kim SW; Son HS; Troya IS; Kim JY; Kim MJ; Fraser MO; Kim JH
Neurourol Urodyn; 2017 Mar; 36(3):677-682. PubMed ID: 27028369
[TBL] [Abstract][Full Text] [Related]
29. Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients.
Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
Int J Urol; 2021 Aug; 28(8):823-830. PubMed ID: 33966299
[TBL] [Abstract][Full Text] [Related]
30. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
31. Early and recent exposure to adversity, TLR-4 stimulated inflammation, and diurnal cortisol in women with interstitial cystitis/bladder pain syndrome: A MAPP research network study.
Lutgendorf SK; Zia S; Luo Y; O'Donnell M; van Bokhoven A; Bradley CS; Gallup R; Pierce J; Taple BJ; Naliboff BD; Quentin Clemens J; Kreder KJ; Schrepf A
Brain Behav Immun; 2023 Jul; 111():116-123. PubMed ID: 37001828
[TBL] [Abstract][Full Text] [Related]
32. Integrated Analysis of Microarray Studies to Identify Novel Diagnostic Markers in Bladder Pain Syndrome/Interstitial Cystitis with Hunner Lesion.
Cheng XF; Zeng ZH; Deng W; Liu YF; Zhou XC; Zhang C; Wang GX
Int J Gen Med; 2022; 15():3143-3154. PubMed ID: 35342305
[TBL] [Abstract][Full Text] [Related]
33. Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients.
Peters KM; Jayabalan N; Bui D; Killinger K; Chancellor M; Tyagi P
Low Urin Tract Symptoms; 2015 May; 7(2):77-83. PubMed ID: 26663686
[TBL] [Abstract][Full Text] [Related]
34. Multimodal Single-Cell Analyses Outline the Immune Microenvironment and Therapeutic Effectors of Interstitial Cystitis/Bladder Pain Syndrome.
Su F; Zhang W; Meng L; Zhang W; Liu X; Liu X; Chen M; Zhang Y; Xiao F
Adv Sci (Weinh); 2022 Jun; 9(18):e2106063. PubMed ID: 35470584
[TBL] [Abstract][Full Text] [Related]
35. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.
Liu HT; Kuo HC
PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581
[TBL] [Abstract][Full Text] [Related]
36. Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes?
Killinger KA; Boura JA; Peters KM
Int Urogynecol J; 2013 Aug; 24(8):1295-301. PubMed ID: 23208005
[TBL] [Abstract][Full Text] [Related]
37. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
38. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
39. Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome.
Warren JW
J Psychosom Res; 2014 Dec; 77(6):510-5. PubMed ID: 25455811
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.
Chen Y; Ying Z; Xiao Y; Liu Y; Wu S
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():156-161. PubMed ID: 34492610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
